acquired
Stage
2
Investors
About
Amakem Therapeutics was a clinical-stage pharmaceutical company based in Germany. It focused on developing novel small molecule therapeutics for inflammatory diseases.
Explore Amakem's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.